Cholesterol as treatment for pneumococcal keratitis: Cholesterol-specific inhibition of pneumolysin in the cornea

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 6, 2007, Pages 2661-2666

  Marquart, Mary E ^a   Monds, Kathryn S ^a   McCormick, Clare C ^a   Dixon, Sherrina N ^a   Sanders, Melissa E ^a   Reed, Julian M ^a   McDaniel, Larry S ^a   Caballero, Armando R ^a   O'Callaghan, Richard J ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; PNEUMOLYSIN; BACTERIAL PROTEIN; EYE DROPS; PLY PROTEIN, STREPTOCOCCUS PNEUMONIAE; STREPTOLYSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; CORNEA; DRUG EFFICACY; DRUG MECHANISM; ERYTHROCYTE; KERATITIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; SLIT LAMP; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; ANIMAL; BACTERIAL COUNT; BACTERIAL EYE INFECTION; CORNEA ULCER; DRUG ANTAGONISM; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ANIMALS; BACTERIAL PROTEINS; CHOLESTEROL; COLONY COUNT, MICROBIAL; CORNEA; CORNEAL ULCER; EYE INFECTIONS, BACTERIAL; MICROBIAL SENSITIVITY TESTS; OPHTHALMIC SOLUTIONS; PNEUMOCOCCAL INFECTIONS; RABBITS; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS;

EID: 34347224405     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.07-0017     Document Type: Article

References (41)

1. Asbell P, Stenson S. Ulcerative keratitis: survey of 30 years' laboratory experience. Arch Ophthalmol. 1982;100:77-80.
2. Clinch TE, Palmon FE, Robinson MJ, Cohen EJ, Barron BA, Laibson PR. Microbial keratitis in children. Am J Ophthalmol. 1994;117:65-71.
3. Cruz OA, Sabir SM, Capo H, Alfonso E. Microbial keratitis in childhood. Ophthalmology. 1993;100:192-196.
4. Dunlop AA, Wright ED, Howlader SA, et al. Suppurative corneal ulceration in Bangladesh: a study of 142 cases examining the microbiological diagnosis, clinical and epidemiological features of bacterial and fungal keratitis. Aust N Z J Ophthalmol. 1994;22:105-110.
5. Gonawardena SA, Ranasinghe KP, Arseculeratne SN, Seimon CR, Ajello L. Survey of mycotic and bacterial keratitis in Sri Lanka. Mycopathologia. 1994;127:77-81.
6. Gudmundsson OG, Ormerod L, Kenyon KR, et al. Factors influencing predilection and outcome in bacterial keratitis. Cornea. 1989;8:115-121.
7. Hagan M, Wright E, Newman M, Dolin P, Johnson G. Causes of suppurative keratitis in Ghana. Br J Ophthalmol. 1995;79:1024-1028.
8. Kunimoto DY, Sharma S, Reddy MK, et al. Microbial keratitis in children. Ophthalmology. 1998;105:252-257.
9. Liesegang TJ, Forster RK. Spectrum of microbial keratitis in South Florida. Am J Ophthalmol. 1980;90:38-47.
10. Ormerod LD, Hertzmark E, Gomez DS, Stabiner RG, Schanzlin DJ, Smith RE. Epidemiology of microbial keratitis in southern California: a multivariate analysis. Ophthalmology. 1987;94:1322-1333.
11. Parmar P, Salman A, Kalavathy CM, Jesudasan CA, Thomas PA. Pneumococcal keratitis: a clinical profile. Clin Exp Ophthalmol. 2003;31:44-47.
12. Schaefer F, Bruttin O, Zografos L, Guex-Crosier Y. Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol. 2001;85:842-847.
13. Srinivasan M, Gonzales CA, George C, et al. Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, South India. Br J Ophthalmol. 1997;81:965-971.
14. Tan DT, Lee CP, Lim AS. Corneal ulcers in two institutions in Singapore: analysis of causative factors, organisms and antibiotic resistance. Ann Acad Med Singapore. 1995;24:823-829.
15. Upadhyay MP, Karmacharya PC, Koirala S, et al. Epidemiologic characteristics, predisposing factors, and etiologic diagnosis of corneal ulceration in Nepal. Am J Ophthalmol. 1991;111:92-99.
16. Williams G, Billson F, Husain R, Howlader SA, Islam N, McClellan K. Microbiological diagnosis of suppurative keratitis in Bangladesh. Br J Ophthalmol. 1987;71:315-321.
17. Soriano F, Perez-Trallero E, Pallares R, et al. Streptococcus pneumoniae endophthalmitis: a study of 36 cases with special reference to antibiotic resistance and treatment options. Clin Microbiol Infect. 2006;12:519-526.
18. Wilkins J, Whitcher JP, Margolis TP. Penicillin-resistant Streptococcus pneumoniae keratitis. Cornea. 1996;15:99-100.
19. Tweten RK. Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins. Infect Immun. 2005;73:6199-6209.
20. Baba H, Kawamura I, Kohda C, et al. Essential role of domain 4 of pneumolysin from Streptococcus pneumoniae in cytolytic activity as determined by truncated proteins. Biochem Biophys Res Commun. 2001;281:37-44.
21. Bonev BB, Gilbert RJ, Andrew PW, Byron O, Watts A. Structural analysis of the protein/lipid complexes associated with pore formation by the bacterial toxin pneumolysin. J Biol Chem. 2001;276:5714-5719.
22. Kelly SJ, Jedrzejas MJ. Structure and molecular mechanism of a functional form of pneumolysin: a cholesterol-dependent cytolysin from Streptococcus pneumoniae. J Struct Biol. 2000;132:72-81.
23. Palmer M, Vulicevic I, Saweljew P, Valeva A, Kehoe M, Bhakdi S. Streptolysin O: a proposed model of allosteric interaction between a pore-forming protein and its target lipid bilayer. Biochemistry. 1998;37:2378-2383.
24. Jounblat R, Kadioglu A, Mitchell TJ, Andrew PW. Pneumococcal behavior and host responses during bronchopneumonia are affected differently by the cytolytic and complement-activating activities of pneumolysin. Infect Immun. 2003;71:1813-1819.
25. Paton JC, Rowan-Kelly B, Ferrante A. Activation of human complement by the pneumococcal toxin pneumolysin. Infect Immun. 1984;43:1085-1087.
26. Rubins JB, Charboneau D, Fasching C, et al. Distinct roles for pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia. Am J Respir Crit Care Med. 1996;153:1339-1346.
27. Rubins JB, Janoff EN. Pneumolysin: a multifunctional pneumococcal virulence factor. J Lab Clin Med. 1998;131:21-27.
28. Johnson MK, Hobden JA, Hagenah M, O'Callaghan RJ, Hill JM, Chen S. The role of pneumolysin in ocular infections with Streptococcus pneumoniae. Curr Eye Res. 1990;9:1107-1114.
29. Johnson MK, Hobden JA, O'Callaghan RJ, Hill JM. Confirmation of the role of pneumolysin in ocular infections with Streptococcus pneumoniae. Curr Eye Res. 1992;11:1221-1225.
30. Johnson MK, Callegan MC, Engel LS, et al. Growth and virulence of a complement-activation-negative mutant of Streptococcus pneumoniae in the rabbit cornea. Curr Eye Res. 1995;14:281-284.
31. Canvin JR, Paton JC, Boulnois GJ, Andrew PW, Mitchell TJ. Streptococcus pneumoniae produces a second haemolysin that is distinct from pneumolysin. Microb Pathogenesis. 1997;22:129-132.
32. Johnson MK, Allen JH. Ocular toxin of the pneumococcus. Am J Ophthalmol. 1971;72:175-180.
33. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard. 7th ed. Wayne, PA; 2006.
34. Thornton J, McDaniel LS. THP-1 monocytes up-regulate intercellular adhesion molecule 1 in response to pneumolysin from Streptococcus pneumoniae. Infect Immun. 2005;73:6493-6498.
35. Johnson MK, Geoffroy C, Alouf JE. Binding of cholesterol by sulfhydryl-activated cytolysins. Infect Immun. 1980;27:97-101.
36. Boulnois GJ, Paton JC, Mitchell TJ, Andrew PW. Structure and function of pneumolysin, the multifunctional, thiol-activated toxin of Streptococcus pneumoniae. Mol Microbiol. 1991;5:2611-2616.
37. Mitchell TJ, Andrew PW, Saunders FK, Smith AN, Boulnois GJ. Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein. Mol Microbiol. 1991;5:1883-1888.
38. Yuste J, Botto M, Paton JC, Holden DW, Brown JS. Additive inhibition of complement deposition by pneumolysin and PspA facilitates Streptococcus pneumoniae septicemia. J Immunol. 2005;175:1813-1819.
39. Spandau UH, Toksoy A, Verhaart S, Gillitzer R, Kruse FE. High expression of chemokines Gro-alpha (CXCL-1), IL-8 (CXCL-8), and MCP-1 (CCL-2) in inflamed human corneas in vivo. Arch Ophthalmol. 2003;121:825-831.
40. Rogers PD, Thornton J, Barker KS, et al. Pneumolysin-dependent and -independent gene expression identified by cDNA microarray analysis of THP-1 human mononuclear cells stimulated by Streptococcus pneumoniae. Infect Immun. 2003;71:2087-2094.
41. Rijneveld AW, van den Dobbelsteen GP, Florquin S, et al. Roles of interleukin-6 and macrophage inflammatory protein-2 in pneumolysin-induced lung inflammation in mice. J Infect Dis. 2002;185:123-126.